Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Rezolute, Inc (RZLT)  
$2.76 0.08 (2.99%) as of 4:30 Wed 5/1


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 33,580,000
Market Cap: 92.68(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.738 - $3.54
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 12.5
Insider 6 Months    : 12.5
Insider 3/6 Months : 24.9
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Rezolute is a clinical-stage biopharmaceutical company developing therapies for metabolic diseases related to chronic glucose imbalance. Co.'s primary clinical asset, RZ358, is a potential treatment for congenital hyperinsulinism, a pediatric genetic disorder characterized by excessive production of insulin by the pancreas. Co.'s second clinical asset, RZ402, is an oral plasma kallikrein inhibitor being developed as a potential therapy for the chronic treatment of diabetic macular edema.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 188,903 188,903 193,903 3,484,876
Total Buy Value $319,782 $319,782 $329,282 $12,834,143
Total People Bought 4 4 4 6
Total Buy Transactions 13 13 14 20
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 138
  Page 1 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Roberts Brian Kenneth Chief Medical Officer   •       •      –    2024-03-28 4 B $2.55 $1,275 I/I 500 1,076 0.01 8%     
   Evans Daron CFO   •       •      –    2024-03-15 4 B $1.69 $33,830 I/I 20,000 20,000 0.01 55%     
   Roberts Brian Kenneth Chief Medical Officer   •       •      –    2024-03-14 4 B $1.88 $18,800 I/I 10,000 10,000 0.01 52%     
   Evans Daron CFO   •       •      –    2024-03-08 4 B $1.93 $96,345 D/D 50,000 120,900 0.01 45%     
   Roberts Brian Kenneth Chief Medical Officer   •       •      –    2024-03-07 4/A B $1.85 $925 I/I 500 576 0.01     -
   Kim Young-Jin   •       •      –    2024-03-07 4 B $1.91 $69,859 D/D 36,503 115,450 0.01 52%     
   Roberts Brian Kenneth Chief Medical Officer   •       •      –    2024-03-07 4 B $1.85 $925 I/I 500 500 0.01 52%     
   Elam Nevan C CEO   •       •      –    2024-02-26 4 B $1.68 $8,400 D/D 5,000 7,817 0.01 68%     
   Roberts Brian Kenneth Chief Medical Officer   •       •      –    2024-02-26 4 B $1.70 $3,400 D/D 2,000 42,552 0.01 68%     
   Roberts Brian Kenneth Chief Medical Officer   •       •      –    2024-02-23 4 B $1.69 $10,140 D/D 6,000 40,552 0.01 60%     
   Roberts Brian Kenneth Chief Medical Officer   •       •      –    2024-02-16 4 B $1.31 $9,142 D/D 7,000 34,552 0.01 104%     
   Evans Daron CFO   •       •      –    2024-02-16 4 B $1.37 $12,330 I/I 9,000 4,500 0.01 104%     
   Evans Daron CFO   •       •      –    2024-02-16 4 B $1.30 $54,411 D/D 41,900 70,900 0.01 104%     
   Evans Daron CFO   •       –      –    2024-01-22 3 IO $0.00 $0 I/I 0 10,000 182%     
   Evans Daron CFO   •       –      –    2024-01-22 3 IO $0.00 $0 D/D 0 29,000 182%     
   Roberts Brian Kenneth Chief Medical Officer   •       •      –    2023-07-03 4 B $1.90 $9,500 D/D 5,000 27,552 0.01 -51%     
   Handok, Inc.   •       •       •   2022-07-22 4 B $3.80 $12,000,001 D/D 3,157,895 5,942,617 0.01 -42%     
   Kim Young-Jin   •       •      –    2022-07-22 4 B $3.80 $299,999 D/D 78,947 78,947 0.01 -42%     
   Roberts Brian Kenneth Sr VP, Clinic Development   •       –      –    2022-05-19 4 B $2.95 $884 D/D 300 22,552 2.66 -10%     
   Roberts Brian Kenneth Sr VP, Clinic Development   •       –      –    2022-05-18 4 B $2.86 $572 D/D 200 22,252 2.66 -2%     
   Roberts Brian Kenneth Sr VP, Clinic Development   •       –      –    2022-05-17 4 B $3.41 $3,407 D/D 1,000 22,052 2.66 -25%     
   Labrucherie Gil M Director   –       •      –    2022-05-04 4/A B $3.80 $199,998 I/I 52,631 53,572 2.1     -
   Handok, Inc.   •       •       •   2021-10-15 4 B $6.50 $5,000,002 D/D 769,231 2,784,722 0.01 -61%     
   Handok, Inc. 10% Owner   –       –       •   2020-10-13 4 AB $23.35 $58,381 D/D 2,500 2,015,491     -
   Handok, Inc. 10% Owner   –       –       •   2020-10-12 4 AB $0.46 $58,113 D/D 125,000 100,649,528     -
  138 Records found
  1  2  3  4  5  6   
  Page 1 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us